Oral Testosterone for the Treatment of Hypogonadism in Males
NCT02222558
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypogonadism
Interventions
DRUG:
TSX-002
Sponsor
TesoRx Pharma, LLC